Selecting antibiotic therapy. From theory to practice;Antibiothérapie sélectionnante. De la théorie à la pratique

Reanimation

Volumn 15, Issue 3, 2006, Pages 198-204

  Skurnik, D ^a   Andremont, A ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Antibiotic; Resistance

Indexed keywords

AMINOPENICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CARBAPENEM; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; ERTAPENEM; IMIPENEM; OFLOXACIN; PEFLOXACIN; QUINOLONE DERIVATIVE; STREPTOMYCIN; TAZOBACTAM; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ENTEROBACTER; ENTEROBACTER INFECTION; HUMAN; KLEBSIELLA; MEDICAL PRACTICE; PERITONITIS; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; URINARY TRACT INFECTION;

EID: 33646814918     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reaurg.2006.03.002     Document Type: Short Survey

References (43)

1. Fleming A. The New York Times 26 (1945) 21
2. Morlock G.P., Plikaytis B.B., and Crawford J.T. Characterization of spontaneous, in vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv. Antimicrob. Agents Chemother. 44 (2000) 3298-3301
3. Neu H.C. Bacterial resistance to fluoroquinolones. Rev. Infect. Dis. 10 Suppl 1 (1988) S57-S63
4. Jacoby G.A., and Munoz-Price L.S. The new betalactamases. N. Engl. J. Med. 352 (2005) 380-391
5. Quinn J.P. Rational antibiotic therapy for intra-abdominal infections. Lancet 349 (1997) 517-518
6. Levy S.B. Antibiotic resistance: consequences of inaction. Clin. Infect. Dis. 33 Suppl 3 (2001) S124-S129
7. Davies J.E. Inactivation of antibiotics and the disseminaiton of resistance genes. Science 264 (1994) 375-382
8. Trieu-Cuot P., Arthur M., and Courvalin P. Origin, evolution and dissemination of antibiotic resistance genes. Microbiol. Sci. 4 (1987) 263-266
9. Soriano F., and Rodriguez-Cerrato V. Pharmacodynamic and kinetic basis for the selection of pneumococcal resistance in the upper respiratory tract. J. Antimicrob. Chemother. 50 Suppl S2 (2002) 51-58
10. Kassis-Chikhani N., Decre D., Gautier V., Burghoffer B., Saliba F., Mathieu D., et al. First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital. J. Antimicrob. Chemother. 57 (2006) 142-145
11. Watanabe T., and Fukasawa T. Resistance transfer factor: an episode in Enterobacteriaceae. Biochem. Biophys. Res. Commun. 3 (1960) 660-665
12. Akiba T., Koyama K., Ishiki Y., Kimura S., and Fukushima T. On the mechanism of the development of multiple-drug resistant clones of Shigella. Jpn. J. Microbiol. 4 (1960) 219-227
13. Watanabe T. Infective heredity of multiple drug resistance in bacteria. Bact. Rev. 27 (1963) 87-115
14. Sykes R., and Richmond M. The intergeneric transfer of a betalactamase gene between Pseudomonas aeruginosa and Escherichia coli. Nature 226 (1970) 952-954
15. Rowe-Magnus D.A., and Mazel D. Resistance gene capture. Curr. Opin. Microbiol. 2 (1999) 483-488
16. Rowe-Magnus D.A., and Mazel D. Integrons: natural tools for bacterial genome evolution. Curr. Opin. Microbiol. 4 (2001) 565-569
17. Rowe-Magnus D.A., and Mazel D. The role of integrons in antibiotic resistance gene capture. Int. J. Med. Microbiol. 292 (2002) 115-125
18. Martinez E., and de la Cruz F. Genetic elements involved in Tn21 site-specific integration, a novel mechanism for the dissemination of antibiotic resistance genes. EMBO J. 9 (1990) 1275-1281
19. Stokes H.W., and Hall R.M. A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol. Microbiol. 3 (1989) 1669-1683
20. Hall R.M., and Collis C.M. Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination. Mol. Microbiol. 15 (1995) 593-600
21. Skurnik D., Le Menac'h A., Zurakowski D., Mazel D., Courvalin P., Denamur E., et al. Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure. Antimicrob. Agents Chemother. 49 (2005) 3062-3065
22. Bartley J. First case of VRSA identified in Michigan. Infect. Control Hosp. Epidemiol. 23 (2002) 480
23. Goldstein F.W., and Acar J.F. Epidemiology of quinolone resistance: Europe and North and South America. Drugs 49 Suppl 2 (1995) 36-42
24. Hiramatsu K., Cui L., Kuroda M., and Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 9 (2001) 486-493
25. French G.L. Enterococci and vancomycin resistance. Clin. Infect. Dis. 27 Suppl 1 (1998) S75-S83
26. Schaberg D.R., Clewell D.B., and Glatzer L. Conjugative transfer of R-plasmids from Streptococcus faecalis to Staphylococcus aureus. Antimicrob. Agents Chemother. 22 (1982) 204-207
27. Horaud T., Le Bouguenec C., and Pepper K. Molecular genetics of resistance to macrolides, lincosamides and streptogramin B (MLS) in streptococci. J. Antimicrob. Chemother. 16 Suppl A (1985) 111-135
28. Noble W.C., Virani Z., and Cree R.G. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 72 (1992) 195-198
29. Kirst H.A., Thompson D.G., and Nicas T.I. Historical yearly usage of vancomycin. Antimicrob. Agents Chemother. 42 (1998) 1303-1304
30. Weigel L.M., Clewell D.B., Gill S.R., Clark N.C., McDougal L.K., Flannagan S.E., et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302 (2003) 1569-1571
31. Centers for Disease Control and Prevention (CDC). Vancomycin-resistant Staphylococcus aureus -- Pennsylvania, 2002. MMWR Morb. Mortal. Wkly. Rep. 51 (2002) 902
32. Vancomycin-resistant Staphylococcus aureus, New York, 2004. MMWR Morb. Mortal. Wkly. Rep. 53 (2004) 322-323
33. Bush K. Why it is important to continue antibacterial drug discovery?. ASM News 70 (2004) 282-287
34. Schaeffer A.J. The expanding role of fluoroquinolones. Am. J. Med. 113 Suppl 1A (2002) 45S-54S
35. Tran J.H., and Jacoby G.A. Mechanism of plasmid-mediated quinolone resistance. Proc. Natl. Acad. Sci. USA 99 (2002) 5638-5642
36. Tran J.H., Jacoby G.A., and Hooper D.C. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob. Agents Chemother. 49 (2005) 118-125
37. Robicsek A., Strahilevitz J., Jacoby G.A., Macielag M., Abbanat D., and Park C.H. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12 (2006) 83-88
38. Craig W.A. Does the dose matter?. Clin. Infect. Dis. 33 Suppl 3 (2001) S233-S237
39. Craig W.A. Overview of newer antimicrobial formulations for overcoming pneumococcal resistance. Am. J. Med. 117 Suppl 3A (2004) 16S-22S
40. Brautigam H.H., Knothe H., and Rangoonwala R. Impact of cefotaxime and ceftriaxone on the bowel and vaginal flora after single-dose prophylaxis in vaginal hysterectomy. Drugs 35 Suppl 2 (1988) 163-168
41. Michea-Hamzehpour M.R., Auckenthaler R., Kunz J., and Pechere J.C. Effect of a single dose of cefotaxime or ceftriaxone on human faecal flora. A double-blind study. Drugs 35 Suppl 2 (1988) 6-11
42. Bourgeois S., Laham A., Besnard M., Andremont A., and Fattal E. In vitro and in vivo evaluation of pectin beads for the colon delivery of betalactamases. J. Drug Target. 13 (2005) 277-284
43. Stiefel U., Harmoinen J., Koski P., Kaariainen S., Wickstrand N., Lindevall K., et al. Orally administered recombinant metallobetalactamase preserves colonization resistance of piperacillin-tazobactam-treated mice. Antimicrob. Agents Chemother. 49 (2005) 5190-5191